Stem Cell Therapies

This channel includes news and new technology innovations about cardiac and peripheral vascular stem cell and gene therapies.

Clive Svendsen, Ph.D., director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, at work in his laboratory. Photo by Cedars-Sinai.

Clive Svendsen, Ph.D., director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, at work in his laboratory. Photo by Cedars-Sinai.

News | Coronavirus (COVID-19) | June 30, 2020
July 30, 2020 — A new study shows that SARS-CoV-2, the virus that causes COVID-19 (coronavirus), can infect heart cells...
BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era
News | Heart Failure | June 30, 2020
June 30, 2020 —  BioCardia, Inc. announced that the company has resumed cases in the CardiAMP Heart Failure Trial. The...
CD34+ Stem Cell Therapy Improved Quality of Life in Patients with Microvascular Dysfunction. #SCAI2020
News | May 17, 2020
May 17, 2020 – Trial results presented today revealed a promising therapy for patients experiencing angina due to...
Renovacor Closes $11 Million Series A Financing for New Cardiovascular Gene Therapy
News | Stem Cell Therapies | August 22, 2019
August 22, 2019 — Renovacor Inc, a preclinical-stage biopharmaceutical company, announced the successful completion of...
Placental Stem Cells Can Regenerate the Heart After Heart Attack
News | Stem Cell Therapies | May 20, 2019
May 20, 2019 – Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated that stem cells derived...
ProxiCor Extracellular Matrix Reduces Complications, Readmissions Following Pericardial Reconstruction
News | Stem Cell Therapies | April 19, 2019
April 19, 2019 — Aziyo Biologics Inc. announced the publication of results from its landmark RECON study in the Journal...
FDA Releases Final Guidances on Regenerative Medicine Therapies
News | Stem Cell Therapies | March 04, 2019
March 4, 2019 — The U.S. Food and Drug Administration (FDA) recently finalized two guidance documents regarding...
Heart Muscle Cells Created From Stem Cells Beat in Sync
News | Stem Cell Therapies | February 01, 2019
February 1, 2019 — A team of Rutgers scientists have taken an important step toward the goal of making diseased hearts...
FDA Clamps Down on Unapproved Stem Cell Therapies
News | Stem Cell Therapies | December 20, 2018
December 20, 2018 — The U.S. Food and Drug Administration (FDA) has warned Genetech Inc. and its president, Edwin N....
NHLBI Pauses CONCERT-HF Heart Failure Trial
News | Heart Failure | October 29, 2018
October 29, 2018 — The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is...
One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon Stertzer, M.D. In this article he shares his views on the current direction and next steps in cardiovascular biomedical technology

Simon Stertzer, M.D., is one of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s and 1980s. He performed the first coronary balloon angioplasty in the United States in 1978.

 

Feature | October 03, 2018
One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon...
Stem Cell Therapy May Offer Treatment for Rare Congenital Cardiac Defect
News | Congenital Heart | February 05, 2018
February 5, 2018 — Children's Hospital Los Angeles announced participation in the first-ever clinical trial using stem...
Humanetics Presents Data on Drug to Protect Cardiac Cells From Space-Like Radiation

Photo from NASA

News | Pharmaceuticals | February 01, 2018
February 1, 2018 –Humanetics Corporation (Humanetics) has recently completed two research studies funded by the...
Secant Introduces First Synthetic Regenerative Cardiovascular Graft for CABG
News | Stem Cell Therapies | January 17, 2018
January 17, 2018 — Secant Group, in partnership with its sister company SanaVita Medical, announced new technology to...
News | Stem Cell Therapies | October 24, 2017
October 24, 2017 — Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate companies...